Supplement Information 2
Studies used in Systematic Review and Meta-Analysis:
1-70
1.Inbar S, Larson J, Burt T, Mafee M, Ezri MD. Case report: nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci1993;305:174-175.
2.Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol1996;19:913-919.
3.Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol1998;21:1336-1339.
4.Garcia-Bolao I, Albaladejo V, Benito A, Alegria E, Zubieta JL. Magnetic resonance imaging in a patient with a dual-chamber pacemaker. Acta Cardiol1998;53:33-35.
5.Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Traber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology2000;215:869-879.
6.Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Luderitz B. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol2001;24:489-495.
7.Anfinsen OG, Berntsen RF, Aass H, Kongsgaard E, Amlie JP. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol2002;25:1400-1402.
8.Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol2004;27:1002-1004.
9.Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol2004;43:1315-1324.
10.Del Ojo JL, Moya F, Villalba J, Sanz O, Pavon R, Garcia D, Pastor L. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol2005;28:274-278.
11.Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol2005;28:1041-1046.
12.Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol2005;28:270-273.
13.Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol2005;28:336-338.
14.Rozner MA, Burton AW, Kumar A. Pacemaker complication during magnetic resonance imaging. J Am Coll Cardiol2005;45:161-162; author reply 162.
15.Wollmann C, Grude M, Tombach B, Kugel H, Heindel W, Breithardt G, Bocker D, Vahlhaus C. Safe performance of magnetic resonance imaging on a patient with an ICD. Pacing Clin Electrophysiol2005;28:339-342.
16.Fritzsche E, Flitsch J, Kucinski T, Lund GK, Papavero L, Westphal M. Diagnosis and treatment of an intramedullary cavernoma in a young male with an implanted cardiac pacemaker. Acta Neurochir (Wien)2006;148:1213-1215; discussion 1215.
17.Goldsher D, Amikam S, Boulos M, Suleiman M, Shreiber R, Eran A, Goldshmid Y, Mazbar R, Roguin A. Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience. Isr Med Assoc J2006;8:91-94.
18.Naehle CP, Sommer T, Meyer C, Strach K, Kreuz J, Litt H, Lewalter T, Schild H, Schwab JO. Strategy for safe performance of magnetic resonance imaging on a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol2006;29:113-116.
19.Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation2006;114:1277-1284.
20.Nemec J. Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging. J Cardiovasc Electrophysiol2006;17:444-445.
21.Sardanelli F, Lupo P, Esseridou A, Fausto A, Quarenghi M. Dynamic breast magnetic resonance imaging without complications in a patient with dual-chamber demand pacemaker. Acta Radiol2006;47:24-27.
22.Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation2006;114:1285-1292.
23.Heatlie G, Pennell DJ. Cardiovascular magnetic resonance at 0.5T in five patients with permanent pacemakers. J Cardiovasc Magn Reson2007;9:15-19.
24.Mikolich JR, Martin ET. Images in cardiovascular medicine. Constrictive pericarditis diagnosed by cardiac magnetic resonance imaging in a pacemaker patient. Circulation2007;115:e191-193.
25.Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol2008;31:795-801.
26.Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol2008;31:1241-1245.
27.Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, Luechinger R, Fimmers R, Schild H, Sommer T. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology2008;249:991-1001.
28.Gimbel JR. Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. Europace2009;11:1241-1242.
29.Goldsher D, Jahshan S, Roguin A. Successful cervical MR scan in a patient several hours after pacemaker implantation. Pacing Clin Electrophysiol2009;32:1355-1356.
30.Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, Litt H, Schwab JO, Schild H, Sommer T. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol2009;54:549-555.
31.Naehle CP, Zeijlemaker V, Thomas D, Meyer C, Strach K, Fimmers R, Schild H, Sommer T. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol2009;32:1526-1535.
32.Pulver AF, Puchalski MD, Bradley DJ, Minich LL, Su JT, Saarel EV, Whitaker P, Etheridge SP. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pacing Clin Electrophysiol2009;32:450-456.
33.Buendia F, Sanchez-Gomez JM, Sancho-Tello MJ, Olague J, Osca J, Cano O, Arnau MA, Igual B. Nuclear magnetic resonance imaging in patients with cardiac pacing devices. Rev Esp Cardiol2010;63:735-739.
34.Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol2010;28:59-66.
35.Halshtok O, Goitein O, Abu Sham'a R, Granit H, Glikson M, Konen E. Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. Isr Med Assoc J2010;12:391-395.
36.Millar LM, Robinson AG, O'Flaherty MT, Eames N, Johnston N, Heyburn G. Magnetic resonance imaging in a patient with a dual chamber pacemaker. Case Rep Med2010;2010:292071.
37.Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace2010;12:947-951.
38.Strach K, Naehle CP, Muhlsteffen A, Hinz M, Bernstein A, Thomas D, Linhart M, Meyer C, Bitaraf S, Schild H, Sommer T. Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace2010;12:952-960.
39.Buendia F, Cano O, Sanchez-Gomez JM, Igual B, Osca J, Sancho-Tello MJ, Olague J, Salvador A. Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices. Europace2011;13:533-538.
40.Dickfeld T, Tian J, Ahmad G, Jimenez A, Turgeman A, Kuk R, Peters M, Saliaris A, Saba M, Shorofsky S, Jeudy J. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol2011;4:172-184.
41.Junttila MJ, Fishman JE, Lopera GA, Pattany PM, Velazquez DL, Williams AR, Trachtenberg BH, Sanina C, Mather J, Hare JM. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart2011;97:1852-1856.
42.Naehle CP, Kreuz J, Strach K, Schwab JO, Pingel S, Luechinger R, Fimmers R, Schild H, Thomas D. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J2011;161:1096-1105.
43.Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med2011;155:415-424.
44.Baser K, Guray U, Durukan M, Demirkan B. High ventricular lead impedance of a DDD pacemaker after cranial magnetic resonance imaging. Pacing Clin Electrophysiol2012;35:e251-253.
45.Boilson BA, Wokhlu A, Acker NG, Felmlee JP, Watson RE, Jr., Julsrud PR, Friedman PA, Cha YM, Rea RF, Hayes DL, Shen WK. Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J Interv Card Electrophysiol2012;33:59-67.
46.Bovenschulte H, Schluter-Brust K, Liebig T, Erdmann E, Eysel P, Zobel C. MRI in patients with pacemakers: overview and procedural management. Dtsch Arztebl Int2012;109:270-275.
47.Cohen JD, Costa HS, Russo RJ. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol2012;110:1631-1636.
48.Maffe S, Paffoni P, Perucca A, Signorotti F, Dellavesa P, Parravicini U. Pseudo "end of life" indication after electromagnetic field exposure: an unusual effect of magnetic resonance imaging on implanted cardioverter defibrillator. Int J Cardiol2012;156:e36-39.
49.Friedman HL, Acker N, Dalzell C, Shen WK, Asirvatham SJ, Cha YM, Hodge D, Felmlee J, Watson R, Friedman PA. Magnetic resonance imaging in patients with recently implanted pacemakers. Pacing Clin Electrophysiol2013;36:1090-1095.
50.Higgins JV, Gard JJ, Sheldon SH, Espinosa RE, Wood CP, Felmlee JP, Cha YM, Asirvatham SJ, Dalzell C, Acker N, Watson RE, Jr., Friedman PA. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol2014;37:1284-1290.
51.Kaasalainen T, Pakarinen S, Kivisto S, Holmstrom M, Hanninen H, Peltonen J, Lauerma K, Sipila O. MRI with cardiac pacing devices - safety in clinical practice. Eur J Radiol2014;83:1387-1395.
52.Mesubi O, Ahmad G, Jeudy J, Jimenez A, Kuk R, Saliaris A, See V, Shorofsky S, Dickfeld T. Impact of ICD artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation. Pacing Clin Electrophysiol2014;37:1274-1283.
53.Muehling OM, Wakili R, Greif M, von Ziegler F, Morhard D, Brueckmann H, Becker A. Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers. J Cardiovasc Magn Reson2014;16:39.
54.Stevens SM, Tung R, Rashid S, Gima J, Cote S, Pavez G, Khan S, Ennis DB, Finn JP, Boyle N, Shivkumar K, Hu P. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. Heart Rhythm2014;11:289-298.
55.Higgins JV, Sheldon SH, Watson RE, Jr., Dalzell C, Acker N, Cha YM, Asirvatham SJ, Kapa S, Felmlee JP, Friedman PA. "Power-on resets" in cardiac implantable electronic devices during magnetic resonance imaging. Heart Rhythm2015;12:540-544.
56.Sheldon SH, Bunch TJ, Cogert GA, et al. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm2015;12:345-349.
57.Ali HE, Gianluca; Sorgente, Antonio; Lupo, Pierpaolo; Cappato, Riccardo. Safety and Utility of Cardiac MRI In A Patient With Pericardial Effusion And A Recently Implanted Conventional Pacemaker. Journal of Atrial Fibrillation2016;9:40-41.
58.Atar I, Bal U, Ertan C, Ozin B, Muderrisoglu H. Inappropriate shock and battery switching to "End of Life" in a patient with biventricular ICD during magnetic resonance imaging. Turk Kardiyol Dern Ars2016;44:79-81.
59.Bertelsen L, Petersen HH, Philbert BT, Svendsen JH, Thomsen C, Vejlstrup N. Safety of magnetic resonance scanning without monitoring of patients with pacemakers. Europace2017;19:818-823.
60.Dandamudi S, Collins JD, Carr JC, et al. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices. Acad Radiol2016;23:1498-1505.
61.Higgins JV, Watson RE, Jr., Jaffe AS, Dalzell C, Acker N, Felmlee JP, Asirvatham SJ, Cha YM, Friedman PA, Kapa S. Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging. J Interv Card Electrophysiol2016;45:91-97.
62.Hwang YM, Kim J, Lee JH, Kim M, Nam GB, Choi KJ, Kim YH. Cardiac Implantable Electronic Device Safety during Magnetic Resonance Imaging. Korean Circ J2016;46:804-810.
63.Njeim M, Yokokawa M, Frank L, Crawford T, Good E, Morady F, Bogun F. Value of Cardiac Magnetic Resonance Imaging in Patients With Failed Ablation Procedures for Ventricular Tachycardia. J Cardiovasc Electrophysiol2016;27:183-189.
64.Gillam MH, Inacio MCS, Pratt NL, Shakib S, Roughead EE. Magnetic Resonance Imaging in People With Cardiac Implantable Electronic Devices: A Population Based Cohort Study. Heart Lung Circ2017.
65.Horwood L, Attili A, Luba F, Ibrahim EH, Parmar H, Stojanovska J, Gadoth-Goodman S, Fette C, Oral H, Bogun F. Magnetic resonance imaging in patients with cardiac implanted electronic devices: focus on contraindications to magnetic resonance imaging protocols. Europace2017;19:812-817.
66.Mason S, Osborn JS, Dhar R, Tonkin A, Ethington JD, Le V, Benuzillo J, Lappe DL, Knowlton KU, Bunch TJ, Anderson JL. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe. J Cardiovasc Electrophysiol2017;28:1468-1474.
67.Russo RJ, Costa HS, Silva PD, et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med2017;376:755-764.
68.Samar H, Yamrozik JA, Williams RB, Doyle M, Shah M, Bonnet CA, Biederman RWW. Diagnostic Value of MRI in Patients With Implanted Pacemakers and Implantable Cardioverter-Defibrillators Across a Cross Population. JACC: Clinical Electrophysiology2017;3:991-1002.
69.Shah AD, Patel AU, Knezevic A, Hoskins MH, Hirsh DS, Merchant FM, El Chami MF, Delurgio DB, Patel AM, Leon AR, Langberg JJ, Lloyd MS. Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices. Pacing Clin Electrophysiol2017;40:467-475.
70.Strom JB, Whelan JB, Shen C, Zheng SQ, Mortele KJ, Kramer DB. Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices. Heart Rhythm2017;14:1138-1144.